Pediatric relapsed/refractory ALK+ anaplastic large cell lymphoma treatment and outcomes in the targeted drug era

Marks, L. J., Ritter, V., Agrusa, J., Kamdar, K. Y., Rivers, J., Gardner, R. A., Ehrhardt, M. J., Devine, K. J., Phillips, C. A., Reilly, A. F., August, K., Weinstein, J. L., Satwani, P., Forlenza, C. J., Smith, C. M., Greer, C., Afify, Z., Lin, C. H., Belsky, J. A., … Aftandilian, C. (2025). Pediatric relapsed/refractory ALK+ anaplastic large cell lymphoma treatment and outcomes in the targeted drug era. Blood Advances. https://doi.org/10.1182/bloodadvances.2024014745
Authors:
Lianna J. Marks
Victor Ritter
Jennifer E. Agrusa
Kala Y. Kamdar
Julie Rivers
Rebecca Gardner
Matthew J. Ehrhardt
Kaitlin J. Devine
Charles Phillips
Anne F. Reilly
Keith J. August
Joanna Weinstein
Prakash Satwani
Christopher J. Forlenza
Christine M. Smith
Chelsee Greer
Zeinab Afify
Carol Lin
Jennifer A. Belsky
Hilda Ding
David J. Hoogstra
Keri Toner
Michael P. Link
Liora M. Schultz
Eric Lowe
Catherine Aftandilian
Affiliated Authors:
Prakash Satwani
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2024014745
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: